Impact factor molecular cancer therapeutics
WitrynaScope. Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular … WitrynaImpact Factor Cancer Discovery: 41.226 Cancer Epidemiology, Biomarkers & Prevention: 5.594 Cancer Immunology Research: 13.345 Cancer Prevention Research: 4.317 …
Impact factor molecular cancer therapeutics
Did you know?
Witryna1 kwi 2024 · BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities Last mentioned on Friday April 7 2024 Quantitative In Vivo … WitrynaCitation Impact 41.444 - 2-year Impact Factor (2024) 30.612 - 5-year Impact Factor (2024) 5.195 - Source Normalized Impact per Paper (SNIP) 6.896 - SCImago Journal …
WitrynaThe latest impact factor of MOLECULAR CANCER THERAPEUTICS and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, … WitrynaMolecular Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1476-4598. ... About Molecular Cancer. Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer ...
Witryna1 kwi 2024 · About the Journal. Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, … MCT First Disclosures. First Disclosures in Molecular Cancer Therapeutics present … Channing J. Der Vishva Dixit Ethan Dmitrovsky Suzanne A. Eccles Heinz … Read Volume 21 Issue 9 of Molecular Cancer Therapeutics. Skip to Main … A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive … Molecular Cancer Research ; Molecular Cancer Therapeutics ; For Authors . … Abstract. Loss of the gene SMARCB1 drives the development of malignant … Abstract. T-cell bispecific antibodies (TCB) are engineered molecules that bind both … Abstract. YES1 is a nonreceptor tyrosine kinase that belongs to the SRC family of … WitrynaJournal impact factor : 0.53 ; Average acceptance to publication time (5-7 days) Average article processing time (30-45 days) Less than 5 volumes 30 days ... Biochimica et Biophysica Acta - Reviews on Cancer, Breast Cancer Research, Neuro-Oncology, Molecular Cancer Therapeutics, Cancer, Journal of Thoracic Oncology.
WitrynaDr Lopamudra Das Roy (Distinguished Cancer Scientist-Research Professor), Social Entrepreneur, resigned from her rewarding career in 2024, to create and grow BCH as her Full-time pro bono ...
Witryna2 dni temu · Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development … eastwest bank cebu careersWitrynaScope. Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to … cumming georgia newspaperWitryna11 sty 2024 · The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, epidemiologic studies, and … east west bank check verificationWitrynaExperience in the developmental genetic factors affecting human brain disorders, rodent and non-rodent animal models and tumor … eastwestbank.com linkedinWitrynaThis special issue published by Molecular Cancer focuses on the clinical aspects of liquid biopsies, in particular validation of novel biomarkers that may serve as signature … east west bank change addressWitrynaMolecular Cancer Therapeutics. Journal Abbreviation: MOL CANCER THER. Journal ISSN: 1535-7163. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 6.009. cumming glassdoorWitryna15 June 2024. About the journal. Aims & Scope. Molecular Therapy Oncolyticsis an international, online-only, open-access journal focusing on the development and … eastwest bank cebu branches